Qiagen NV, the Netherlands-based holding company for the German diagnostics company of the same name, is offering to buy Ipsogen SA of France in two stages for approximately €70 million starting with the purchase of a 47% stake. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
